Pyrimidinone compounds which are HNE inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9868740
SERIAL NO

15317274

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIESI FARMACEUTICI S P AVIA PALERMO 26/A PARMA 43122

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alcaraz, Lilian Harlow, GB 36 219
Armani, Elisabetta Parma, IT 69 430
Capaldi, Carmelida Parma, IT 32 122
Heald, Robert Andrew Harlow, GB 29 148
Sutton, Jonathan Mark Harlow, GB 37 203

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 16, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 16, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00